# Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis

> **NCT00133627** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 229 (actual)

## Conditions studied

- Seasonal Allergic Conjunctivitis

## Interventions

- **DRUG:** Ketotifen

## Key facts

- **NCT ID:** NCT00133627
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2011-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133627, "Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00133627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*